|
|
||||||
Haematologica Future Titles
Influence of sickle cell disease and treatment by hydroxyurea on sperm parameters
and fertility of human males
Isabelle Berthaut, Geoffroy Guignedoux, Frederique Kirsch-Noir, Vanina de Larouziere,
Celia Ravel, Dora Bachir, Frederic Galacteros, Pierre-Yves Ancel, Jean-Marie
Kunstmann, Laurence Levy, Pierre Jouannet, Robert Girot and Jacqueline Mandelbaum
Genome-wide analysis of copy number changes and loss of heterozygosity in
myelodysplastic syndrome with del(5q) using high-density single nucleotide
polymorphism arrays
Li Wang, Carrie Fidler, Nandita Nadig, Aristoteles Giagounidis, Matteo G. Della
Porta, Luca Malcovati, Sally Killick, Norbert Gattermann, Carlo Aul, Jacqueline
Boultwood and James S Wainscoat
Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment
with the SRC/ABL inhibitor dasatinib
Alice Fabarius, Michelle Giehl, Blanka Rebacz, Alwin Krämer, Oliver Frank,
Claudia Haferlach, Peter Duesberg, Rüdiger Hehlmann, Wolfgang Seifarth and
Andreas Hochhaus
Aberrant expression of microRNA in polycythemia vera
Hana Bruchova, Michaela Merkerova and Josef T. Prchal
Prognostic Impact of genetic characterization in the GIMEMA LAM99P Multi-Center
study for newly diagnosed acute myeloid leukemia
Francesco Lo-Coco, Antonio Cuneo, Fabrizio Pane, Daniela Cilloni, Daniela Diverio,
Marco Mancini, Nicoletta Testoni, Antonella Bardi, Barbara Izzo,
Niccolň Bolli, Roberta La Starza, Paola Fazi, Simona Iacobelli, Alfonso Piciocchi,
Marco Vignetti, Sergio Amadori, Franco Mandelli, Pier Giuseppe Pelicci, Cristina
Mecucci, Brunangelo Falini, Giuseppe Saglio for the Acute Leukemia Working
Party of the GIMEMA group
M4 acute myeloid leukemia: role of eosinophilia and cytogenetics on treatment
response and survival. The GIMEMA experience
Alessandro Pulsoni, Simona Iacobelli, Massimo Bernardi, Marco Borgia, Andrea
Camera, Nicola Cantore, Francesco Di Raimondo, Paola Fazi, Felicetto Ferrara,
Franco Leoni, Vincenzo Liso, Marco Mancini, Filippo Marmont, Angela Matturro,
Luca Maurillo, Lorella Melillo, Giovanna Meloni, Salvo Mirto, Giorgina Specchia,
Caterina Giovanna Valentini, Adriano Venditti, Giuseppe Leone, Robin Foŕ, Franco
Mandelli and Livio Pagano
Gene expression analysis provides a potential rationale for revising the
histological grading of follicular lymphomas
Pier Paolo Piccaluga, Andrea Califano, Ulf Klein, Claudio Agostinelli, Beatriz
Bellosillo, Eva Gimeno, Sergi Serrano, Francisco Solč, Yonghui Zang, Brunangelo
Falini, Pier Luigi Zinzani and Stefano A. Pileri
FK506 and transforming growth factor b signaling and apoptosis in chronic
lymphocytic leukemia B cells
Simona Romano, Maria Mallardo, Federico Chiurazzi, Rita Bisogni, Anna D’Angelillo,
Raffaele Liuzzi, Giovanna Compare and Maria Fiammetta Romano
A bioluminescence imaging based in vivo model for preclinical testing of
novel cellular immunotherapy strategies to improve the graft-versus-myeloma
effect
Henk Rozemuller, Ellen van der Spek, Lijnie H. Bogers-Boer, Mieke C. Zwart,
Vivienne Verweij, Maarten Emmelot, Richard W. Groen, Robbert Spaapen, Andries
C. Bloem, Henk M. Lokhorst,Tuna Mutis and Anton C. Martens
Granulocyte concentrates: prolonged functional capacity during storage in
the presence of phenotypic changes
Agata Drewniak, Jaap-Jan Boelens, Hans Vrielink, Anton T.J. Tool, Marrie C.A.
Bruin, Marry van den Heuvel, Lynne Ball, Marianne D. van de Wetering, Dirk
Roos and Taco W. Kuijpers
A study of 36 unrelated cases with pure erythrocytosis revealed three new
mutations in the erythropoietin receptor gene
Maha Al-Sheikh, Elodie Mazurier, Betty Gardie, Nicole Casadevall, Frédéric
Galactéros, Michel Goossens, Henri Wajcman, Claude Préhu and Valérie Ugo
Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid
leukemia: identification of novel fusion transcripts and cloning of genomic
breakpoint junctions
Nuno Cerveira, Francesca Micci, Joana Santos, Manuela Pinheiro, Cecília Correia,
Susana Lisboa, Susana Bizarro, Lucília Norton, Anders Glomstein, Ann E. Ĺsberg,
Sverre Heim and Manuel R. Teixeira
Transcriptional activation of the cardiac homeobox gene CSX1/NKX2-5 in a
B-cell chronic lymphoproliferative disorder
Xinying Su, Véronique Della-Valle, Eric Delabesse, Zahia Azgui, Roland Berger,
Hélčne Merle-Béral, Olivier A Bernard and Florence Nguyen-Khac
Mutations affecting MRNA splicing are the most common molecular defect in
patients with familial hemophagocytic lymphohistiocytosis type 3
Alessandra Santoro, Sonia Cannella, Antonino Trizzino, Giuseppa Bruno, Carmen
De Fusco, Luigi D. Notarangelo, Daniela Pende, Gillian M. Griffiths, Maurizio
Aricň
No evidence of cardiac iron in 20 never or minimally transfused patients
with thalassemia intermedia
Raffaella Origa, Susanna Barella, Giovanni Maria Argiolas, Patrizio Bina, Annalisa
Agus, Renzo Galanello
Defective mRNA levels are responsible for a beta-thalassemia phenotype associated
with Hb Federico II, a novel hemoglobin variant [beta-106 (G8) Leu->Val]
Michela Grosso, Ilaria Palumbo, Emanuela Morelli, Stella Puzone, Raffaele Sessa,
Paola Izzo
Oligoarray CGH in polycythemia vera and essential thrombocythemia
Ioana Borze, Satu Mustjokio, Eeva Juvonen, Sakari Knuutila
Angiogenesis in pulmonary hypertension with myelofibrosis
Eva Zetterberg, Uday Popa, Hans Hasselbalch, Josef Prchal, Jan Palmblad
Low-dose thalidomide in myelofibrosis
Robert Weinkove, Johm T. Reilly, Mary Frances McMullin, Natasha J Curtin, Deepti
Radia, Claire N Harrison
Increased cortical bone mineralization in imatinib treated patients with chronic
myelogenous leukemia
Sofia Jönsson, Bob Olsson, Claes Ohlsson, Mattias Lorentzon, Dan Mellström,
Hans Wadenvik
Heterogeneous promoter activity of the telomerase reverse transcriptase gene
in idividual acute myeloid leukemia cells defined by lentiviral reporter
assay
Seiichiro Kobayashi, Yasushi Soda, Yuansong Bai, Arinobu Tojo
Expression of the nuclear oncogene Ski in patients with acute myeloid leukemia
treated with all-trans retinoic acid
Sabine Teichler, Richard F. Schlenk, Konstantin Strauch, Nicole Hagner, Markus
Ritter, Andreas Neubauer
NOTCH2 mutations in marginal zone lymphoma
Gunhild Trřen, Iwona Wlodarska, Abdirashid Warsame, Silvia Hernández Llodrŕ,
Christiane De Wolf-Peeters, Jan Delabie
The IL6(-174G/C) polymorphism is a prognostic factor for survival after treatment
initiation in Waldenström macroglobulinemia patients aged 65 years or less
Stéphanie Poulain, Isabelle Dervite, Xavier Leleu, Valérie Coiteux, Patrick
Duthilleul, Pierre Morel
The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease
characteristics in chronic lymphocytic leukemia (CLL)
Thorsten Zenz, Sonja Häbe, Axel Benner, Dirk Kienle, Hartmut Döhner, Stephan
Stilgenbauer
Is there any role for low-dose cyclosporine in refractory immune thrombocytopenic
purpura ?
Giovanni Emilia, Mario Luppi, Monica Morselli, Fabio Forghieri, Leonardo Potenza,
Giuseppe Torelli
Elevated factor XIII level and the risk of peripheral artery disease
Amir H. Shemirani, Edit Szomják, Zoltán Csiki, Éva Katona, Zsuzsanna Bereczky,
László Muszbek
IgM anti-protein S antibodies as a risk factor for venous thrombosis
Montserrat Borrell, Isabel Tirado, José Mateo, Artur Oliver, Amparo Santamaría,
Jordi Fontcuberta
Antiplatelet drugs and risk of venous thromboembolism: results from the EDITH
case-control study
Karine Lacut, Jantien van der Maaten, Grégoire Le Gal, Géraldine Cornily, Dominique
Mottier, Emmanuel Oger
| HOME | HELP | FEEDBACK | ARCHIVE | SUBSCRIPTIONS |